| __timestamp | Madrigal Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 68205000 | 31354781 |
| Thursday, January 1, 2015 | 54218000 | 43445817 |
| Friday, January 1, 2016 | 15934000 | 66489820 |
| Sunday, January 1, 2017 | 24390000 | 96886134 |
| Monday, January 1, 2018 | 25389000 | 153793000 |
| Tuesday, January 1, 2019 | 72324000 | 148369000 |
| Wednesday, January 1, 2020 | 184809000 | 151934000 |
| Friday, January 1, 2021 | 205164000 | 198532000 |
| Saturday, January 1, 2022 | 245441000 | 112128000 |
| Sunday, January 1, 2023 | 271823000 | 76192000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Madrigal Pharmaceuticals, Inc. and TG Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Madrigal Pharmaceuticals increased its R&D spending by nearly 300%, peaking in 2023 with a 272% rise compared to 2014. In contrast, TG Therapeutics saw a more modest growth of approximately 143% over the same period, with a notable peak in 2021. This divergence highlights Madrigal's aggressive push towards innovation, particularly in recent years, while TG Therapeutics has maintained a steady, albeit slower, pace. As these companies continue to navigate the competitive biotech sector, their R&D strategies will be pivotal in shaping their future breakthroughs.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Research and Development Expenses Breakdown: Amgen Inc. vs Madrigal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
R&D Insights: How Genmab A/S and Madrigal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
Incyte Corporation or Madrigal Pharmaceuticals, Inc.: Who Invests More in Innovation?
BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending